SCHEMBL16145030

SCHEMBL16145030

CC(O)c1ccc2c(c1N)C(=O)c1ccccc1C2=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 8/20 0.60
▸ MAPT P10636 8/20 0.60
▸ ALDH1A1 P00352 7/20 0.60
▸ SMN1; SMN2 Q16637 7/20 0.60
▸ MEN1 O00255 6/20 0.60
▸ KMT2A Q03164 6/20 0.60
▸ L3MBTL1 Q9Y468 5/20 0.60
▸ RAB9A P51151 5/20 0.60
▸ TDP1 Q9NUW8 5/20 0.60
▸ POLB P06746 4/20 0.60
▸ NPC1 O15118 4/20 0.60
▸ LMNA P02545 3/20 0.60
▸ CYP3A4 P08684 3/20 0.60
▸ MCL1 Q07820 3/20 0.60
▸ THRB P10828 2/20 0.60
▸ TSHR P16473 2/20 0.60
▸ CASP3 P42574 1/20 0.60
▸ HBB P68871 1/20 0.60
▸ SENP7 Q9BQF6 1/20 0.60
▸ SENP6 Q9GZR1 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28158735 0.90 MAPK1 (0.64) MAPK1MAPTALDH1A1SMN1; SMN2MEN1
SCHEMBL30985958 0.85 MAPK1 (0.62) MAPK1MAPTALDH1A1SMN1; SMN2MEN1
SCHEMBL10940842 0.79 ALDH1A1 (0.50) MAPK1MAPTALDH1A1SMN1; SMN2MEN1
SCHEMBL5053437 0.79 MEN1 (0.56) MAPK1MAPTALDH1A1SMN1; SMN2MEN1
SCHEMBL6289054 0.78 MAPK1 (0.57) MAPK1MAPTALDH1A1SMN1; SMN2MEN1
SCHEMBL8744278 0.77 MAPT (0.73) MAPK1MAPTALDH1A1SMN1; SMN2MEN1
SCHEMBL397171 0.75 MEN1 (1.00) MAPK1MAPTALDH1A1SMN1; SMN2MEN1
SCHEMBL591041 0.75 ALDH1A1 (1.00) MAPK1MAPTALDH1A1SMN1; SMN2MEN1
SCHEMBL29558186 0.75 ALDH1A1 (1.00) MAPK1MAPTALDH1A1SMN1; SMN2MEN1
SCHEMBL487001 0.74 MAOA (1.00) MAPK1MAPTALDH1A1SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9261803-B2 Electrophotographic belt and electrophotographic image forming apparatus CANON KABUSHIKI KAISHA (JP) 2016-02-16 — — US disclosed
US-20140301759-A1 ELECTROPHOTOGRAPHIC BELT AND ELECTROPHOTOGRAPHIC IMAGE FORMING APPARATUS CANON KABUSHIKI KAISHA (JP) 2014-10-09 — — US disclosed
US-20110127513-A1 NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME LG CHEM, LTD. (KR) 2011-06-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110127513-A1 NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME VDAC2, VDAC1, VDAC3 MAPK1 2780/4885MAPT 2655/4885ALDH1A1 2949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback